Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat sodium in sepsis-induced ARDS
NCT05672472Unknown
- Sponsor
- The First Hospital of Jilin University
- Start
- Jan 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of sivelestat in acute respiratory distress syndrome (ARDS), sponsored by The First Hospital of Jilin University. Primary endpoint: Duration of mechanical ventilation at 2 years. Status: unknown.
02
Drugs
sivelestat
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT05672472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05672472.